KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020 


• No. 1 platform in rare diseases expected to generate 65% of total annual revenues 

• Multiple, durable billion-dollar franchises, each with best-in-class products 

• Robust portfolio includes over 30 recent and planned product launches with $5 billion sales potential by 2020 

• Efficient structure expected to yield annual operating cost synergies of over $500 million, with additional revenue synergies and a combined non-GAAP effective tax rate of 16-17% 

• Accretion to non-GAAP diluted EPS anticipated in 2017, the first full calendar year of ownership, and beyond 

• Attractive ROIC expected to exceed Shire’s cost of capital in 2020 

• Wayne T. Hockmeyer, Baxalta’s Chairman, expected to become Deputy Chairman, and two additional Directors to be included from the Baxalta Board 

Read the full press release here